Portfolio company
QuantaLife
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops digital polymerase chain reaction systems for laboratories to identify and quantify DNA molecules for genetic analysis and disease diagnosis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Dropworks
This company develops digital PCR instruments for highly sensitive nucleic acid quantification for life science and diagnostic researchers.
Stilla Technologies
This company develops digital PCR instruments and genetic analysis tests for researchers and clinicians in the pharmaceutical, clinical and life sciences sectors.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Quanterix
This company develops ultra-sensitive biomarker detection platforms and assay kits for pharmaceutical companies, academic institutions, and clinical laboratories.
Cellular Research
This company develops single-cell genetic analysis tools for academic and industrial researchers to quantify gene expression in individual cells.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
Life Technologies
This company provides laboratory instruments and consumables to researchers, pharmaceutical firms and clinical laboratories for genetic analysis and life science discovery.
Anvil Diagnostics
This company develops molecular blood tests to identify and quantify pathogens in hospitalised patients using digital PCR hardware.
